CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Treatment resistance affects nearly half of all young people experiencing moderate-to-
severe anxiety. In this 12-week open-label trial, patients received add-on CBD after no
clinical improvement on therapy with CBT and/or antidepressant medication. There was
a more than 40% reduction in mean OASIS scores and no serious or unexpected
adverse events.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
